Creso Pharma Limited filed its Annual on Feb 28, 2022 for the period ending Dec 31, 2021. In this report its auditor, BDO LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 AUD | 0.00% | -40.00% | -92.50% |
16/04 | Melodiol Global's Revenue Surges 79% in Q1 | MT |
09/04 | Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic | MT |
1st Jan change | Capi. | |
---|---|---|
-92.50% | 1.32M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ME1 Stock
- News Melodiol Global Health Limited
- Creso Pharma Limited Auditor Raises 'Going Concern' Doubt